Symptoms of overdose include drowsiness, slurred speech, motor inco-ordination, coma, and respiratory depression.
Withdrawn in the United Kingdom due to risk of psychiatric adverse drug reactions. This drug continues to be available in the U.S. Internationally, triazolam is a Schedule IV drug under the Convention on Psychotropic Substances.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Hydrocodone | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Magnesium sulfate | The therapeutic efficacy of Triazolam can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Metyrosine | Triazolam may increase the sedative activities of Metyrosine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Mirtazapine | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Orphenadrine | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Pramipexole | Triazolam may increase the sedative activities of Pramipexole. |
| Ropinirole | Triazolam may increase the sedative activities of Ropinirole. |
| Rotigotine | Triazolam may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Triazolam. |
| Suvorexant | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Thalidomide | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Clozapine | The risk or severity of adverse effects can be increased when Triazolam is combined with Clozapine. |
| Methadone | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Methadone. |
| Sodium oxybate | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Teduglutide | The serum concentration of Triazolam can be increased when it is combined with Teduglutide. |
| Yohimbine | The therapeutic efficacy of Triazolam can be increased when used in combination with Yohimbine. |
| Erythromycin | The serum concentration of Triazolam can be increased when it is combined with Erythromycin. |
| Sirolimus | The serum concentration of Triazolam can be increased when it is combined with Sirolimus. |
| Dirithromycin | The serum concentration of Triazolam can be increased when it is combined with Dirithromycin. |
| Telithromycin | The serum concentration of Triazolam can be increased when it is combined with Telithromycin. |
| Candicidin | The serum concentration of Triazolam can be increased when it is combined with Candicidin. |
| Clarithromycin | The serum concentration of Triazolam can be increased when it is combined with Clarithromycin. |
| Josamycin | The serum concentration of Triazolam can be increased when it is combined with Josamycin. |
| Everolimus | The serum concentration of Triazolam can be increased when it is combined with Everolimus. |
| Epothilone D | The serum concentration of Triazolam can be increased when it is combined with Epothilone D. |
| Patupilone | The serum concentration of Triazolam can be increased when it is combined with Patupilone. |
| 6-Deoxyerythronolide B | The serum concentration of Triazolam can be increased when it is combined with 6-Deoxyerythronolide B. |
| Ixabepilone | The serum concentration of Triazolam can be increased when it is combined with Ixabepilone. |
| KOS-1584 | The serum concentration of Triazolam can be increased when it is combined with KOS-1584. |
| Ridaforolimus | The serum concentration of Triazolam can be increased when it is combined with Ridaforolimus. |
| Temsirolimus | The serum concentration of Triazolam can be increased when it is combined with Temsirolimus. |
| AVE9633 | The serum concentration of Triazolam can be increased when it is combined with AVE9633. |
| Coltuximab ravtansine | The serum concentration of Triazolam can be increased when it is combined with Coltuximab ravtansine. |
| Cethromycin | The serum concentration of Triazolam can be increased when it is combined with Cethromycin. |
| Mitemcinal | The serum concentration of Triazolam can be increased when it is combined with Mitemcinal. |
| Brefeldin A | The serum concentration of Triazolam can be increased when it is combined with Brefeldin A. |
| Solithromycin | The serum concentration of Triazolam can be increased when it is combined with Solithromycin. |
| Kitasamycin | The serum concentration of Triazolam can be increased when it is combined with Kitasamycin. |
| Carbomycin | The serum concentration of Triazolam can be increased when it is combined with Carbomycin. |
| Doramectin | The serum concentration of Triazolam can be increased when it is combined with Doramectin. |
| Eprinomectin | The serum concentration of Triazolam can be increased when it is combined with Eprinomectin. |
| Oleandomycin | The serum concentration of Triazolam can be increased when it is combined with Oleandomycin. |
| Selamectin | The serum concentration of Triazolam can be increased when it is combined with Selamectin. |
| Tildipirosin | The serum concentration of Triazolam can be increased when it is combined with Tildipirosin. |
| Tilmicosin | The serum concentration of Triazolam can be increased when it is combined with Tilmicosin. |
| Tylosin | The serum concentration of Triazolam can be increased when it is combined with Tylosin. |
| Tylvalosin | The serum concentration of Triazolam can be increased when it is combined with Tylvalosin. |
| Bryostatin 1 | The serum concentration of Triazolam can be increased when it is combined with Bryostatin 1. |
| Lorvotuzumab mertansine | The serum concentration of Triazolam can be increased when it is combined with Lorvotuzumab mertansine. |
| Epofolate | The serum concentration of Triazolam can be increased when it is combined with Epofolate. |
| Sagopilone | The serum concentration of Triazolam can be increased when it is combined with Sagopilone. |
| Troleandomycin | The serum concentration of Triazolam can be increased when it is combined with Troleandomycin. |
| Miocamycin | The serum concentration of Triazolam can be increased when it is combined with Miocamycin. |
| Flurithromycin | The serum concentration of Triazolam can be increased when it is combined with Flurithromycin. |
| Rokitamycin | The serum concentration of Triazolam can be increased when it is combined with Rokitamycin. |
| Midecamycin | The serum concentration of Triazolam can be increased when it is combined with Midecamycin. |
| Clindamycin | The serum concentration of Triazolam can be increased when it is combined with Clindamycin. |
| Mepartricin | The serum concentration of Triazolam can be increased when it is combined with Mepartricin. |
| Flumazenil | Flumazenil may decrease the sedative activities of Triazolam. |
| Saquinavir | The serum concentration of Triazolam can be increased when it is combined with Saquinavir. |
| Itraconazole | The metabolism of Triazolam can be decreased when combined with Itraconazole. |
| Simeprevir | The serum concentration of Triazolam can be increased when it is combined with Simeprevir. |
| Ethanol | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Triazolam may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Triazolam. |
| Trazodone | The risk or severity of adverse effects can be increased when Triazolam is combined with Trazodone. |
| Sibutramine | The risk or severity of adverse effects can be increased when Triazolam is combined with Sibutramine. |
| Escitalopram | The risk or severity of adverse effects can be increased when Triazolam is combined with Escitalopram. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Triazolam is combined with Levomilnacipran. |
| Ritanserin | The risk or severity of adverse effects can be increased when Triazolam is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Triazolam is combined with Alaproclate. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Triazolam is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Triazolam is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Triazolam is combined with Duloxetine. |
| Paroxetine | The risk or severity of adverse effects can be increased when Triazolam is combined with Paroxetine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Triazolam is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Triazolam is combined with Dapoxetine. |
| Milnacipran | The risk or severity of adverse effects can be increased when Triazolam is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Triazolam is combined with Desvenlafaxine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Triazolam is combined with Seproxetine. |
| Indalpine | The risk or severity of adverse effects can be increased when Triazolam is combined with Indalpine. |
| Benzatropine | Benzatropine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
| Cyproheptadine | The risk or severity of CNS depression can be increased when Cyproheptadine is combined with Triazolam. |
| Propiomazine | The risk or severity of CNS depression can be increased when Propiomazine is combined with Triazolam. |
| Propantheline | Propantheline may decrease the excretion rate of Triazolam which could result in a higher serum level. |
| Dicyclomine | Dicyclomine may decrease the excretion rate of Triazolam which could result in a higher serum level. |
| Flavoxate | Triazolam may decrease the excretion rate of Flavoxate which could result in a higher serum level. |
| Aclidinium | Triazolam may decrease the excretion rate of Aclidinium which could result in a higher serum level. |